This would be the worst-case scenario for health companies, according UBS By: MarketWatch June 19, 2019 at 17:08 PM EDT Health-care reform is coming, UBS analysts say, and it could have severe consequences for certain health companies. Read More >> Related Stocks: Amgen Bayer Aktienges ADR Bristol-Myers Squibb Celgene Corp Gilead Sciences Incyte Corp Ipsen S.A. ADR Merck Kgaa Novartis Ag ADR Regeneron Pharmaceuticals Roche Holding AG Basel American Depositary Shares Sanofi-Aventis S.A. ADR
